First News
First News
First News
First News
First News
New generation of SiiMA Screening launches with Cervical Cancer Screening

About:
Launch
SiiMA Screening
Published:
A more modern, robust, secure and intuitive platform, used daily by thousands of healthcare professionals
In September 2026, First concluded the upgrade of SiiMA Screening to the new SiiMA Vision Rastreios version in the Cervical Cancer Screening (RCCU) module. This is the first screening programme to benefit from the new generation of the solution, which adopts the most modern technologies and offers a more robust, secure and intuitive platform.
SiiMA Screening is used daily, from North to South of the country, by thousands of healthcare professionals in primary healthcare, hospitals, laboratories, and other entities participating in screening programmes. The solution supports complex workflows designed specifically for screening, covering the entire pathway from invitations to consultations or examinations through to diagnosis, treatment, and patient follow-up, featuring interoperability with other clinical and laboratory systems.
For these professionals, the new version adds new functionalities with a more user-friendly and intuitive interface, designed to make everyday work more agile and allow teams to focus on patient care and monitoring.
For institutions, the new architecture reinforces the application's robustness, availability, and security, making its maintenance and ongoing development simpler and faster.
SiiMA Screening has been a nationwide solution for over 15 years, and the new version is already in use across mainland Portugal. The rollout on the ground was planned and executed to minimise solution downtime as much as possible, ensuring the continuity of screening programmes and team workflows throughout the entire process.
The new platform has received very positive feedback from end users, confirming gains in simplicity and efficiency in the day-to-day operations of screening programmes.
In the coming months, upgrades are planned for the Diabetic Retinopathy Screening and Child Visual Health Screening, followed by Colorectal Cancer and Breast Cancer Screening.
This evolution is part of First's commitment to continuously modernise its healthcare solutions, making them more efficient, accessible, and prepared to meet the needs of institutions while improving care delivered to patients.
About SiiMA Screening
SiiMA Screening is First's solution for managing the end-to-end pathway of population-based and opportunistic screening programmes for Cervical Cancer, Colorectal Cancer, Breast Cancer, Diabetic Retinopathy, and Child Visual Health.
Find out more about SiiMA Screening here.


